Cargando…
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy)
Selection of lung cancer patients for therapy with tyrosine kinase inhibitors directed at EGFR requires the identification of specific EGFR mutations. In most patients with advanced, inoperable lung carcinoma limited tumor samples often represent the only material available for both histologic typin...
Autores principales: | de Biase, Dario, Visani, Michela, Malapelle, Umberto, Simonato, Francesca, Cesari, Valentina, Bellevicine, Claudio, Pession, Annalisa, Troncone, Giancarlo, Fassina, Ambrogio, Tallini, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871524/ https://www.ncbi.nlm.nih.gov/pubmed/24376723 http://dx.doi.org/10.1371/journal.pone.0083607 |
Ejemplares similares
-
Cytology in the time of coronavirus disease (COVID-19): an Italian perspective
por: Vigliar, Elena, et al.
Publicado: (2021) -
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review
por: Pisapia, Pasquale, et al.
Publicado: (2019) -
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test
por: De Luca, Caterina, et al.
Publicado: (2017) -
Next generation sequencing in cytology
por: Pisapia, Pasquale, et al.
Publicado: (2021) -
Allele Specific Locked Nucleic Acid Quantitative PCR (ASLNAqPCR): An Accurate and Cost-Effective Assay to Diagnose and Quantify KRAS and BRAF Mutation
por: Morandi, Luca, et al.
Publicado: (2012)